main Conference Invited Speakers' Page

Invited Speakers' Page

S1
The Future of Asian Big Data Based Precision Medicine


  • Yeup Yoon

    Professor, Sungkyunkwan University


  • Raul Rabadan

    Professor, Columbia University


  • Kah-Hoe Pierce CHOW

    Professor, Duke-NUS Medical School, National Cancer Centre Singapore


  • Yiu-Lian Fong

    Global Head, Johnson & Johnson


  • Do-Hyun Nam

    Professor, Samsung Medical Center

S2
AI & Big Data in Healthcare


  • Young-Hak Kim

    Director, Asan Medical Center


  • Seong Ho Park

    Professor, Asan Medical Center


  • Cheng-Kai Kao

    Associate Chief Medical Information Officer, Uchicago Medicine


  • Jong Chul Ye

    Endowed Chair Professor, KAIST


  • Chiwon In

    CSO, Kakaobrain


  • Raniero Pittini

    Head of Research Medtech and Head of Engineering, Switzerland Innovation Park Biel/Bienne


  • Eunsol Lee

    CEO, Medibloc


  • NamKug Kim

    Professor, Asan Medical Center


  • Yeha Lee

    CEO, VUNO Inc.


  • Anthony S. Paek

    Co-Founder, CEO, Lunit


  • SeokJin Han

    Technology Solutions Professional, Microsoft

S3
Future Prospect of Bio-3D Printing Technology for Medical Innovation


  • YOUNG CHEOL KIM

    Professor, Kyungpook National University


  • Youngmee, Jung

    Principle Research Scientist, Korea Institute of Science and Technology


  • Chang Hun, Lee

    Professor, Columbia University Medical Center


  • Jungsung, Kim

    Professor, Konyang University

S4
How Do We Regulate Healthcare Innovation?


  • Gyu Ha Ryu

    Professor, Sungkyunkwan Univ.


  • Yoon Sup Choi

    Director, Digital Healthcare Institute


  • KIM, YONG-WOO

    Advisor, KIM&CHANG


  • Soo-Yong Shin

    Assistant Professor, Sungkyunkwan University

  • Young-kyu Kang

    Deputy Director, Ministry of Food and Drug Safety


  • Anthony Seungwook Paek

    CEO, Lunit


  • Hyun-Jun Kim

    CSO, VUNO

S5
Immuno-Oncology Therapies


  • Agustin de la Calle

    CBO, Eutilex Co.Ltd


  • Khurram Nawaz

    Director, Decision Resources Group


  • Kyu Tae Kim

    Director, AbClon


  • Jaeho Jung

    Vice President, ABL Bio


  • Morihiro Watanabe

    Head, Merck Serono

S6
Bridge Investment


  • James Jungkue Lee

    CEO, Bridge Bio

  • Young Guk Cho

    CEO, Global Venture Network


  • Ron Heffernan

    CEO & Managing Partner, Mountain Pacific VC


  • June Chen

    CEO, LDD Partners

S7
Global Market Strategy for Biosimilar


  • Jean Paul Deslypere

    Professor, University Hospital of Gent, Belgium


  • Hugo DeWit

    Managing Director, Sartorius Stedim Cellca GmbH


  • John Moys

    Director, Thermo Scientific Finesse BioProduction


  • Jae Hyun Kim

    Director, GE Healthcare

  • Michael Kim

    CEO, Prestige Bio


  • Jin Pub Son

    Director, DM BIo Limited


  • Bang Kue Ho

    Professor, Gyeongnam National University of Science and Technology

S8
Medical Technologies Based on Neuroscience


  • Jaeseung Jeong

    Professor, Korea Advanced Institute of Science and Technology


  • Kiwon Lee

    Founder and CEO, YBRAIN


  • Olivier Salvado

    , CSIRO


  • Ae-Nim Pae

    Chief, Korea Institute of Science and Technology

S9
Licensing and Investment Strategies for Global (Bio) Pharmaceutical Development

  • Andy Jang

    CEO, STASSETS INVESTMENT


  • Michael Chen

    Head of External Innovation Asia region, Merck


  • Jean De Serres

    Vice President, Paladin Labs

  • Yuan Hua Ding

    Senior Director and Head , pfizer


  • Jiang Fei

    Executive Director, Guijing Capital


  • Cedric Bisson

    Partner, Teralys Capital


  • Kevin Lin

    Vice Director, Fortune Venture Capital Co.Ltd.

S10
Global Regulatory & Commercial Outlook in Cell & Gene Therapy / Opportunities in Global Regenerative Medicine Markets


  • Antonio Lee

    Global Head, MEDIPOST


  • Tim Farries

    Director, ERA Consulting


  • Colin Novick

    Managing Director, CJ Partners


  • Mingping Zhang

    VP, PAREXEL Consulting

S11
Regulatory Strategy for Cell & Gene Therapy


  • Antonio Lee

    Global Head, MEDIPOST


  • GUANG GAO

    Principle Consultant, Axteria Biomed Consulting Inc.


  • Mark Wood

    Head of Data Services, Crown CRO


  • Richard Adair

    Virology Manager, SGS Vitrology


  • Philip Ridley-Smith

    Sales & Marketing Director , Cobra biologics

S12
IP Disputes and Countermeasures in Cell Therapies


  • Eunkyeong Lee

    , BKL


  • Mi-Kyung Son

    Senior Staff, PIPC(Patent Information Promotion Center)


  • Peter Kang

    Associate, Wilson Sonsini Goodrich & Rosati


  • Robert Andrews

    Partner, Patent Attorney, Mewburn Ellis LLP


  • Kieran Williams

    Principal & Patent Attorney, Shelston IP

S17
INVEST FAIR


  • Byungmo Kang

    Team leader, Korea Exchange KOSDAQ Center

  • Junghee Lim

    Managing Director, Intervest


  • Skip Fleshman

    Partner, Asset Management Ventures


  • Jeiwook Chae

    Chief Business Officer, LegoChem Biosciences Inc.


  • Yeong Ok Baik

    CEO, Eubiologics Co.Ltd


  • Keivin Lin

    Vice Director, Fortune Capital Co.Ltd


  • Hoil Choi

    Founder & CEO, Peptron


  • Jun Ho Kim

    Director, Amicogen. Inc.


  • Ted Byung Chan Moon

    Managing Director, RM GLOBAL


  • Stan Kim

    Managing Director, Eyegene. Inc.

S18
Bio-Health Cluster Forum


  • Ning Ding

    Deputy Chief Executive First Deputy Commander, The People’s Government of Wenjiang District, Chengdu


  • Shi An YANG

    Director, Yantai Business Representative Office in South Korea​


  • Sooyoung Ji

    CEO Assistant, Power & Legend (Hunan) Health Industry Investment Co., Ltd.


  • Zhaoyang Liu

    Deputy Mayor


  • Nicholas Cho

    COO, Simnogen Biotech. Ltd.


  • Weimin Yang

    Vice-Director, National Yancheng Economic-Technological Development Zone


  • Je Sang Lee

    Chief, Daegu Medical Innovation Foundation

  • Chul Kim

    General Manager, Osong Medical Innovation Foundation

S19
Human Microbiome: Current Aspects and Upcoming Developments